We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+7.48%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$87.3M
(+3.3%)
Cap. Flow
-$60.5M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
488
New
83
Increased
40
Reduced
117
Closed
75
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$45.9M |
| 2 |
Gilead Sciences
GILD
|
+$45.4M |
| 3 |
Illinois Tool Works
ITW
|
+$30.4M |
| 4 |
Edwards Lifesciences
EW
|
+$29.3M |
| 5 |
DST
DST Systems Inc.
DST
|
+$27.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RHT
Red Hat Inc
RHT
|
+$48.5M |
| 2 |
Visa
V
|
+$35.8M |
| 3 |
Masco
MAS
|
+$29.9M |
| 4 |
Keurig Dr Pepper
KDP
|
+$29.6M |
| 5 |
Stryker
SYK
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.67% |
| 2 | Industrials | 14.97% |
| 3 | Healthcare | 14.7% |
| 4 | Consumer Discretionary | 13.7% |
| 5 | Consumer Staples | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TBRA
176
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $1.22M | 0.04% |
+19,890
| New | +$1.21M |
2014 Q2
0 quarters
|
|
|
RCPT
177
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $1.21M | 0.04% |
28,500
-1,410
| -5% | -$48.7K |
2014 Q1
1 quarter
|
|
178
Quaker Houghton
KWR
$2.73B
| $1.2M | 0.04% |
15,655
-1,010
| -6% | -$76.7K |
2013 Q3
3 quarters
|
|
179
Insmed
INSM
$21.7B
| $1.09M | 0.04% |
54,580
-2,630
| -5% | -$38.9K |
2014 Q1
1 quarter
|
|
180
Verastem
VSTM
$836M
| $1.07M | 0.04% |
9,817
-479
| -5% | -$52.1K |
2013 Q4
2 quarters
|
|
181
Inovio Pharmaceuticals
INO
$108M
| $974K | 0.04% |
+7,509
| New | +$886K |
2014 Q2
0 quarters
|
|
182
Alaunos Therapeutics
TCRT
$5.54M
| $957K | 0.04% |
1,583
+565
| +56% | +$315K |
2014 Q1
1 quarter
|
|
183
Arrowhead Research
ARWR
$8.26B
| $905K | 0.03% |
+63,210
| New | +$829K |
2014 Q2
0 quarters
|
|
184
HNI Corp
HNI
$3.4B
| $870K | 0.03% |
+22,245
| New | +$813K |
2014 Q2
0 quarters
|
|
|
HPTX
185
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $838K | 0.03% |
+32,110
| New | +$825K |
2014 Q2
0 quarters
|
|
|
BLT
186
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $828K | 0.03% |
+58,700
| New | +$713K |
2014 Q2
0 quarters
|
|
187
DELISTED
Civitas Resources
CIVI
| $798K | 0.03% |
+125
| New | +$707K |
2014 Q2
0 quarters
|
|
188
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $795K | 0.03% |
17,128
-221
| -1% | -$10.3K |
2013 Q2
4 quarters
|
|
189
TG Therapeutics
TGTX
$8.57B
| $770K | 0.03% |
81,989
-112,712
| -58% | -$721K |
2013 Q4
2 quarters
|
|
190
DELISTED
Molecular Templates, Inc.
MTEM
| $757K | 0.03% |
1,158
-55
| -5% | -$36.4K |
2013 Q3
3 quarters
|
|
191
LendingTree
TREE
$363M
| $740K | 0.03% |
+25,390
| New | +$692K |
2014 Q2
0 quarters
|
|
|
NAVG
192
DELISTED
Navigators Group Inc
NAVG
| $720K | 0.03% |
21,466
-820
| -4% | -$25.2K |
2013 Q2
4 quarters
|
|
193
FerroAtlántica
GSM
$736M
| $717K | 0.03% |
34,520
-1,510
| -4% | -$30.4K |
2013 Q4
2 quarters
|
|
194
HCI Group
HCI
$2.44B
| $713K | 0.03% |
17,561
+1,900
| +12% | +$73.5K |
2013 Q3
3 quarters
|
|
|
SYKE
195
DELISTED
SYKES Enterprises Inc
SYKE
| $696K | 0.03% |
+32,010
| New | +$649K |
2014 Q2
0 quarters
|
|
|
FRTX
196
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $643K | 0.02% |
+167
| New | +$628K |
2014 Q2
0 quarters
|
|
197
Hyster-Yale Materials Handling
HY
$540M
| $481K | 0.02% |
5,429
+5,297
| +4,013% | +$481K |
2013 Q3
3 quarters
|
|
|
SHPG
198
DELISTED
Shire pic
SHPG
| $415K | 0.02% |
1,764
| – | – |
2013 Q4
2 quarters
|
|
|
AIMC
199
DELISTED
Altra Industrial Motion Corp
AIMC
| $379K | 0.01% |
10,418
-85,432
| -89% | -$3M |
2014 Q1
1 quarter
|
|
200
TAL Education Group
TAL
$6.96B
| $319K | 0.01% |
69,546
| – | – |
2013 Q4
2 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Smith Group Asset Management held 488 positions worth $2.71B, up 3.3% from $2.62B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Smith Group Asset Management's Q2 2014 filing shows 83 new, 40 increased, 117 reduced and 75 closed positions. Its largest new stake was Illinois Tool Works: 353,400 shares worth $30.9M. The largest sale was Red Hat Inc, an estimated $48.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
- Smith Group Asset Management's largest Q2 2014 buy was Illinois Tool Works: 353,400 shares worth $30.9M.
- Smith Group Asset Management added most to Apple in Q2 2014, an estimated $45.9M increase.
- Smith Group Asset Management's biggest Q2 2014 reduction was Stryker, cutting an estimated $29.6M.
- Smith Group Asset Management fully exited Red Hat Inc in Q2 2014, selling an estimated $48.5M.
- Smith Group Asset Management's ten largest holdings make up 23% of its $2.71B portfolio in Q2 2014.
- Smith Group Asset Management opened 83 new positions and closed 75 in Q2 2014.
- Smith Group Asset Management's portfolio value rose 3.3% quarter-over-quarter to $2.71B.
Based on Smith Group Asset Management's 13F filing for Q2 2014, filed 23 Jul 2014.